nodes	percent_of_prediction	percent_of_DWPC	metapath
Apomorphine—HTR1D—meninx—brain cancer	0.044	0.0679	CbGeAlD
Apomorphine—HTR1B—dura mater—brain cancer	0.0418	0.0645	CbGeAlD
Apomorphine—HTR1D—dura mater—brain cancer	0.0405	0.0625	CbGeAlD
Apomorphine—HTR2C—choroid plexus—brain cancer	0.0341	0.0526	CbGeAlD
Apomorphine—HTR1B—trigeminal nerve—brain cancer	0.018	0.0277	CbGeAlD
Apomorphine—DRD3—telencephalic ventricle—brain cancer	0.018	0.0277	CbGeAlD
Apomorphine—HTR1D—trigeminal nerve—brain cancer	0.0174	0.0269	CbGeAlD
Apomorphine—HTR2A—choroid plexus—brain cancer	0.0171	0.0264	CbGeAlD
Apomorphine—DRD1—telencephalic ventricle—brain cancer	0.0129	0.0198	CbGeAlD
Apomorphine—HTR1B—cranial nerve—brain cancer	0.0128	0.0198	CbGeAlD
Apomorphine—HTR1D—cranial nerve—brain cancer	0.0124	0.0191	CbGeAlD
Apomorphine—Contusion—Lomustine—brain cancer	0.0118	0.0559	CcSEcCtD
Apomorphine—DRD5—ganglion—brain cancer	0.0105	0.0162	CbGeAlD
Apomorphine—HTR1B—telencephalic ventricle—brain cancer	0.0104	0.0161	CbGeAlD
Apomorphine—HTR1D—telencephalic ventricle—brain cancer	0.0101	0.0156	CbGeAlD
Apomorphine—HTR2C—telencephalic ventricle—brain cancer	0.00999	0.0154	CbGeAlD
Apomorphine—HTR2A—trigeminal nerve—brain cancer	0.00865	0.0133	CbGeAlD
Apomorphine—HTR2A—cerebellar cortex—brain cancer	0.00862	0.0133	CbGeAlD
Apomorphine—HTR1A—telencephalic ventricle—brain cancer	0.00841	0.013	CbGeAlD
Apomorphine—DRD1—ganglion—brain cancer	0.00801	0.0123	CbGeAlD
Apomorphine—CALY—telencephalon—brain cancer	0.00799	0.0123	CbGeAlD
Apomorphine—HTR2A—vein—brain cancer	0.00782	0.0121	CbGeAlD
Apomorphine—DRD2—telencephalic ventricle—brain cancer	0.0076	0.0117	CbGeAlD
Apomorphine—CALY—pituitary gland—brain cancer	0.0065	0.01	CbGeAlD
Apomorphine—HTR1B—ganglion—brain cancer	0.00649	0.01	CbGeAlD
Apomorphine—HTR1D—ganglion—brain cancer	0.00628	0.00968	CbGeAlD
Apomorphine—CALY—medulla oblongata—brain cancer	0.00628	0.00968	CbGeAlD
Apomorphine—HTR2C—ganglion—brain cancer	0.00622	0.00959	CbGeAlD
Apomorphine—HTR2A—cranial nerve—brain cancer	0.00617	0.0095	CbGeAlD
Apomorphine—HTR2A—pons—brain cancer	0.00609	0.00939	CbGeAlD
Apomorphine—CALY—midbrain—brain cancer	0.00574	0.00884	CbGeAlD
Apomorphine—CALY—spinal cord—brain cancer	0.0056	0.00863	CbGeAlD
Apomorphine—HTR1A—ganglion—brain cancer	0.00524	0.00807	CbGeAlD
Apomorphine—HTR1B—blood vessel—brain cancer	0.00516	0.00795	CbGeAlD
Apomorphine—CALY—endocrine gland—brain cancer	0.00504	0.00777	CbGeAlD
Apomorphine—HTR2A—telencephalic ventricle—brain cancer	0.00501	0.00773	CbGeAlD
Apomorphine—HTR1D—blood vessel—brain cancer	0.005	0.0077	CbGeAlD
Apomorphine—CALY—head—brain cancer	0.00497	0.00767	CbGeAlD
Apomorphine—DRD2—ganglion—brain cancer	0.00473	0.00729	CbGeAlD
Apomorphine—CALY—central nervous system—brain cancer	0.00454	0.007	CbGeAlD
Apomorphine—CALY—cerebellum—brain cancer	0.00444	0.00684	CbGeAlD
Apomorphine—HTR2A—pineal body—brain cancer	0.00435	0.0067	CbGeAlD
Apomorphine—Injection site reaction—Carmustine—brain cancer	0.00407	0.0193	CcSEcCtD
Apomorphine—DRD5—telencephalon—brain cancer	0.00404	0.00623	CbGeAlD
Apomorphine—Sweating increased—Procarbazine—brain cancer	0.004	0.0189	CcSEcCtD
Apomorphine—Angina pectoris—Procarbazine—brain cancer	0.004	0.0189	CcSEcCtD
Apomorphine—HTR1A—hindbrain—brain cancer	0.00397	0.00612	CbGeAlD
Apomorphine—Pneumonia—Procarbazine—brain cancer	0.00368	0.0174	CcSEcCtD
Apomorphine—Drowsiness—Procarbazine—brain cancer	0.00366	0.0173	CcSEcCtD
Apomorphine—CALY—brain—brain cancer	0.0036	0.00556	CbGeAlD
Apomorphine—DRD2—hindbrain—brain cancer	0.00359	0.00553	CbGeAlD
Apomorphine—DRD1—brainstem—brain cancer	0.00348	0.00537	CbGeAlD
Apomorphine—Swelling—Carmustine—brain cancer	0.00337	0.016	CcSEcCtD
Apomorphine—Hallucination—Procarbazine—brain cancer	0.00327	0.0155	CcSEcCtD
Apomorphine—ADRA1D—telencephalon—brain cancer	0.00324	0.005	CbGeAlD
Apomorphine—HTR2A—ganglion—brain cancer	0.00312	0.00481	CbGeAlD
Apomorphine—DRD1—telencephalon—brain cancer	0.00309	0.00476	CbGeAlD
Apomorphine—Flushing—Procarbazine—brain cancer	0.00305	0.0144	CcSEcCtD
Apomorphine—Drowsiness—Hydroxyurea—brain cancer	0.00283	0.0134	CcSEcCtD
Apomorphine—HTR1B—brainstem—brain cancer	0.00282	0.00435	CbGeAlD
Apomorphine—DRD4—brain—brain cancer	0.00277	0.00427	CbGeAlD
Apomorphine—HTR1D—brainstem—brain cancer	0.00273	0.00421	CbGeAlD
Apomorphine—HTR2C—brainstem—brain cancer	0.0027	0.00417	CbGeAlD
Apomorphine—HTR2A—endothelium—brain cancer	0.00269	0.00415	CbGeAlD
Apomorphine—DRD3—head—brain cancer	0.00269	0.00414	CbGeAlD
Apomorphine—Dehydration—Temozolomide—brain cancer	0.00267	0.0126	CcSEcCtD
Apomorphine—Swelling—Etoposide—brain cancer	0.00261	0.0123	CcSEcCtD
Apomorphine—Syncope—Procarbazine—brain cancer	0.00257	0.0121	CcSEcCtD
Apomorphine—DRD5—endocrine gland—brain cancer	0.00255	0.00393	CbGeAlD
Apomorphine—Cardiac failure congestive—Etoposide—brain cancer	0.00253	0.012	CcSEcCtD
Apomorphine—Hallucination—Hydroxyurea—brain cancer	0.00253	0.012	CcSEcCtD
Apomorphine—DRD5—head—brain cancer	0.00252	0.00388	CbGeAlD
Apomorphine—Loss of consciousness—Procarbazine—brain cancer	0.00251	0.0119	CcSEcCtD
Apomorphine—HTR1B—telencephalon—brain cancer	0.0025	0.00386	CbGeAlD
Apomorphine—HTR2A—blood vessel—brain cancer	0.00248	0.00383	CbGeAlD
Apomorphine—DRD3—central nervous system—brain cancer	0.00245	0.00378	CbGeAlD
Apomorphine—Arthralgia—Procarbazine—brain cancer	0.00244	0.0115	CcSEcCtD
Apomorphine—Anxiety—Procarbazine—brain cancer	0.00243	0.0115	CcSEcCtD
Apomorphine—HTR1D—telencephalon—brain cancer	0.00242	0.00374	CbGeAlD
Apomorphine—Sweating increased—Temozolomide—brain cancer	0.00242	0.0114	CcSEcCtD
Apomorphine—HTR2C—telencephalon—brain cancer	0.0024	0.0037	CbGeAlD
Apomorphine—HTR2A—hindbrain—brain cancer	0.00237	0.00365	CbGeAlD
Apomorphine—Confusional state—Procarbazine—brain cancer	0.00235	0.0111	CcSEcCtD
Apomorphine—Vomiting—Lomustine—brain cancer	0.00234	0.0111	CcSEcCtD
Apomorphine—Oedema—Procarbazine—brain cancer	0.00233	0.0111	CcSEcCtD
Apomorphine—Pneumonia—Carmustine—brain cancer	0.0023	0.0109	CcSEcCtD
Apomorphine—DRD5—central nervous system—brain cancer	0.0023	0.00354	CbGeAlD
Apomorphine—Shock—Procarbazine—brain cancer	0.0023	0.0109	CcSEcCtD
Apomorphine—HTR1A—brainstem—brain cancer	0.00228	0.00351	CbGeAlD
Apomorphine—Hyperhidrosis—Procarbazine—brain cancer	0.00226	0.0107	CcSEcCtD
Apomorphine—HTR2B—telencephalon—brain cancer	0.00225	0.00348	CbGeAlD
Apomorphine—Urinary tract infection—Carmustine—brain cancer	0.00223	0.0105	CcSEcCtD
Apomorphine—Pneumonia—Temozolomide—brain cancer	0.00223	0.0105	CcSEcCtD
Apomorphine—DRD1—midbrain—brain cancer	0.00222	0.00342	CbGeAlD
Apomorphine—Nausea—Lomustine—brain cancer	0.00218	0.0103	CcSEcCtD
Apomorphine—Hypotension—Procarbazine—brain cancer	0.00218	0.0103	CcSEcCtD
Apomorphine—Urinary tract infection—Temozolomide—brain cancer	0.00215	0.0102	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00213	0.0101	CcSEcCtD
Apomorphine—Insomnia—Procarbazine—brain cancer	0.00211	0.01	CcSEcCtD
Apomorphine—Somnolence—Procarbazine—brain cancer	0.00208	0.00983	CcSEcCtD
Apomorphine—ADRA1B—head—brain cancer	0.00206	0.00318	CbGeAlD
Apomorphine—DRD2—brainstem—brain cancer	0.00206	0.00317	CbGeAlD
Apomorphine—Hallucination—Carmustine—brain cancer	0.00205	0.00969	CcSEcCtD
Apomorphine—ADRA1D—endocrine gland—brain cancer	0.00204	0.00315	CbGeAlD
Apomorphine—HTR1A—telencephalon—brain cancer	0.00202	0.00311	CbGeAlD
Apomorphine—ADRA1D—head—brain cancer	0.00202	0.00311	CbGeAlD
Apomorphine—Fatigue—Procarbazine—brain cancer	0.00201	0.00953	CcSEcCtD
Apomorphine—Constipation—Procarbazine—brain cancer	0.002	0.00945	CcSEcCtD
Apomorphine—Hallucination—Temozolomide—brain cancer	0.00198	0.00936	CcSEcCtD
Apomorphine—DRD3—brain—brain cancer	0.00195	0.003	CbGeAlD
Apomorphine—Sweating increased—Etoposide—brain cancer	0.00194	0.00916	CcSEcCtD
Apomorphine—Feeling abnormal—Procarbazine—brain cancer	0.00192	0.00911	CcSEcCtD
Apomorphine—DRD1—head—brain cancer	0.00192	0.00297	CbGeAlD
Apomorphine—Flushing—Carmustine—brain cancer	0.00191	0.00904	CcSEcCtD
Apomorphine—HTR2C—medulla oblongata—brain cancer	0.00189	0.00291	CbGeAlD
Apomorphine—ADRA1B—central nervous system—brain cancer	0.00188	0.0029	CbGeAlD
Apomorphine—Flushing—Temozolomide—brain cancer	0.00184	0.00873	CcSEcCtD
Apomorphine—ADRA1D—central nervous system—brain cancer	0.00184	0.00284	CbGeAlD
Apomorphine—DRD2—telencephalon—brain cancer	0.00182	0.00281	CbGeAlD
Apomorphine—DRD5—brain—brain cancer	0.00182	0.00281	CbGeAlD
Apomorphine—Oedema—Hydroxyurea—brain cancer	0.00181	0.00856	CcSEcCtD
Apomorphine—Mental disorder—Carmustine—brain cancer	0.0018	0.00853	CcSEcCtD
Apomorphine—HTR1B—midbrain—brain cancer	0.0018	0.00277	CbGeAlD
Apomorphine—Pneumonia—Etoposide—brain cancer	0.00178	0.00844	CcSEcCtD
Apomorphine—ADRA2C—telencephalon—brain cancer	0.00177	0.00274	CbGeAlD
Apomorphine—DRD1—central nervous system—brain cancer	0.00176	0.00271	CbGeAlD
Apomorphine—HTR1B—spinal cord—brain cancer	0.00175	0.0027	CbGeAlD
Apomorphine—Mental disorder—Temozolomide—brain cancer	0.00174	0.00824	CcSEcCtD
Apomorphine—HTR1D—midbrain—brain cancer	0.00174	0.00268	CbGeAlD
Apomorphine—Back pain—Carmustine—brain cancer	0.00173	0.0082	CcSEcCtD
Apomorphine—HTR2C—midbrain—brain cancer	0.00172	0.00266	CbGeAlD
Apomorphine—HTR2C—spinal cord—brain cancer	0.00168	0.00259	CbGeAlD
Apomorphine—Asthenia—Procarbazine—brain cancer	0.00168	0.00793	CcSEcCtD
Apomorphine—Back pain—Temozolomide—brain cancer	0.00167	0.00792	CcSEcCtD
Apomorphine—Pruritus—Procarbazine—brain cancer	0.00165	0.00782	CcSEcCtD
Apomorphine—Dyspnoea—Hydroxyurea—brain cancer	0.00161	0.00763	CcSEcCtD
Apomorphine—Somnolence—Hydroxyurea—brain cancer	0.00161	0.00761	CcSEcCtD
Apomorphine—Diarrhoea—Procarbazine—brain cancer	0.0016	0.00756	CcSEcCtD
Apomorphine—HTR1B—endocrine gland—brain cancer	0.00158	0.00243	CbGeAlD
Apomorphine—HTR1B—head—brain cancer	0.00156	0.0024	CbGeAlD
Apomorphine—Fatigue—Hydroxyurea—brain cancer	0.00156	0.00738	CcSEcCtD
Apomorphine—Constipation—Hydroxyurea—brain cancer	0.00155	0.00732	CcSEcCtD
Apomorphine—Dizziness—Procarbazine—brain cancer	0.00154	0.00731	CcSEcCtD
Apomorphine—Chest pain—Carmustine—brain cancer	0.00152	0.00722	CcSEcCtD
Apomorphine—Anxiety—Carmustine—brain cancer	0.00152	0.00719	CcSEcCtD
Apomorphine—HTR1D—head—brain cancer	0.00151	0.00233	CbGeAlD
Apomorphine—ADRA1B—brain—brain cancer	0.0015	0.00231	CbGeAlD
Apomorphine—HTR2C—head—brain cancer	0.00149	0.0023	CbGeAlD
Apomorphine—Feeling abnormal—Hydroxyurea—brain cancer	0.00149	0.00705	CcSEcCtD
Apomorphine—DRD2—pituitary gland—brain cancer	0.00149	0.00229	CbGeAlD
Apomorphine—Vomiting—Procarbazine—brain cancer	0.00148	0.00703	CcSEcCtD
Apomorphine—Flushing—Etoposide—brain cancer	0.00148	0.00699	CcSEcCtD
Apomorphine—Confusional state—Carmustine—brain cancer	0.00147	0.00697	CcSEcCtD
Apomorphine—Arthralgia—Temozolomide—brain cancer	0.00147	0.00697	CcSEcCtD
Apomorphine—Anxiety—Temozolomide—brain cancer	0.00147	0.00695	CcSEcCtD
Apomorphine—ADRA1D—brain—brain cancer	0.00146	0.00226	CbGeAlD
Apomorphine—Headache—Procarbazine—brain cancer	0.00146	0.00693	CcSEcCtD
Apomorphine—Oedema—Carmustine—brain cancer	0.00146	0.00692	CcSEcCtD
Apomorphine—HTR1A—midbrain—brain cancer	0.00145	0.00224	CbGeAlD
Apomorphine—ADRA2C—pituitary gland—brain cancer	0.00144	0.00223	CbGeAlD
Apomorphine—Confusional state—Temozolomide—brain cancer	0.00142	0.00674	CcSEcCtD
Apomorphine—HTR1B—central nervous system—brain cancer	0.00142	0.00219	CbGeAlD
Apomorphine—ADRA2A—telencephalon—brain cancer	0.00142	0.00218	CbGeAlD
Apomorphine—HTR1A—spinal cord—brain cancer	0.00142	0.00218	CbGeAlD
Apomorphine—Oedema—Temozolomide—brain cancer	0.00141	0.00668	CcSEcCtD
Apomorphine—HTR2B—head—brain cancer	0.0014	0.00216	CbGeAlD
Apomorphine—ADRA2C—medulla oblongata—brain cancer	0.00139	0.00215	CbGeAlD
Apomorphine—DRD1—brain—brain cancer	0.00139	0.00215	CbGeAlD
Apomorphine—Nausea—Procarbazine—brain cancer	0.00139	0.00657	CcSEcCtD
Apomorphine—HTR1D—central nervous system—brain cancer	0.00138	0.00212	CbGeAlD
Apomorphine—Hypotension—Carmustine—brain cancer	0.00137	0.00646	CcSEcCtD
Apomorphine—Hyperhidrosis—Temozolomide—brain cancer	0.00136	0.00646	CcSEcCtD
Apomorphine—HTR2C—central nervous system—brain cancer	0.00136	0.0021	CbGeAlD
Apomorphine—HTR2A—brainstem—brain cancer	0.00136	0.00209	CbGeAlD
Apomorphine—Back pain—Etoposide—brain cancer	0.00134	0.00634	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Carmustine—brain cancer	0.00133	0.0063	CcSEcCtD
Apomorphine—Insomnia—Carmustine—brain cancer	0.00132	0.00626	CcSEcCtD
Apomorphine—DRD2—midbrain—brain cancer	0.00131	0.00202	CbGeAlD
Apomorphine—Dyspnoea—Carmustine—brain cancer	0.0013	0.00617	CcSEcCtD
Apomorphine—Somnolence—Carmustine—brain cancer	0.0013	0.00615	CcSEcCtD
Apomorphine—Asthenia—Hydroxyurea—brain cancer	0.0013	0.00614	CcSEcCtD
Apomorphine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.00129	0.00609	CcSEcCtD
Apomorphine—HTR2B—central nervous system—brain cancer	0.00128	0.00198	CbGeAlD
Apomorphine—Insomnia—Temozolomide—brain cancer	0.00128	0.00605	CcSEcCtD
Apomorphine—ADRA2C—midbrain—brain cancer	0.00127	0.00196	CbGeAlD
Apomorphine—HTR1A—endocrine gland—brain cancer	0.00127	0.00196	CbGeAlD
Apomorphine—Dyspnoea—Temozolomide—brain cancer	0.00126	0.00596	CcSEcCtD
Apomorphine—HTR1A—head—brain cancer	0.00126	0.00194	CbGeAlD
Apomorphine—Somnolence—Temozolomide—brain cancer	0.00126	0.00594	CcSEcCtD
Apomorphine—Constipation—Carmustine—brain cancer	0.00125	0.00591	CcSEcCtD
Apomorphine—ADRA2C—spinal cord—brain cancer	0.00124	0.00192	CbGeAlD
Apomorphine—Diarrhoea—Hydroxyurea—brain cancer	0.00124	0.00585	CcSEcCtD
Apomorphine—Fatigue—Temozolomide—brain cancer	0.00122	0.00576	CcSEcCtD
Apomorphine—Loss of consciousness—Etoposide—brain cancer	0.00122	0.00576	CcSEcCtD
Apomorphine—Constipation—Temozolomide—brain cancer	0.00121	0.00572	CcSEcCtD
Apomorphine—Feeling abnormal—Carmustine—brain cancer	0.0012	0.0057	CcSEcCtD
Apomorphine—HTR2A—telencephalon—brain cancer	0.0012	0.00186	CbGeAlD
Apomorphine—Dizziness—Hydroxyurea—brain cancer	0.00119	0.00566	CcSEcCtD
Apomorphine—ADRA2A—gonad—brain cancer	0.00118	0.00182	CbGeAlD
Apomorphine—Chest pain—Etoposide—brain cancer	0.00118	0.00558	CcSEcCtD
Apomorphine—Feeling abnormal—Temozolomide—brain cancer	0.00116	0.00551	CcSEcCtD
Apomorphine—ADRA2A—pituitary gland—brain cancer	0.00115	0.00178	CbGeAlD
Apomorphine—DRD2—endocrine gland—brain cancer	0.00115	0.00177	CbGeAlD
Apomorphine—Vomiting—Hydroxyurea—brain cancer	0.00115	0.00544	CcSEcCtD
Apomorphine—HTR1A—central nervous system—brain cancer	0.00115	0.00177	CbGeAlD
Apomorphine—Confusional state—Etoposide—brain cancer	0.00114	0.00539	CcSEcCtD
Apomorphine—DRD2—head—brain cancer	0.00114	0.00175	CbGeAlD
Apomorphine—Headache—Hydroxyurea—brain cancer	0.00113	0.00536	CcSEcCtD
Apomorphine—HTR1B—brain—brain cancer	0.00113	0.00174	CbGeAlD
Apomorphine—HTR1A—cerebellum—brain cancer	0.00112	0.00173	CbGeAlD
Apomorphine—ADRA2A—medulla oblongata—brain cancer	0.00111	0.00171	CbGeAlD
Apomorphine—ADRA2C—head—brain cancer	0.0011	0.0017	CbGeAlD
Apomorphine—HTR1D—brain—brain cancer	0.00109	0.00169	CbGeAlD
Apomorphine—Hyperhidrosis—Etoposide—brain cancer	0.00109	0.00517	CcSEcCtD
Apomorphine—HTR2C—brain—brain cancer	0.00108	0.00167	CbGeAlD
Apomorphine—Nausea—Hydroxyurea—brain cancer	0.00107	0.00508	CcSEcCtD
Apomorphine—Hypotension—Etoposide—brain cancer	0.00106	0.005	CcSEcCtD
Apomorphine—Asthenia—Carmustine—brain cancer	0.00105	0.00496	CcSEcCtD
Apomorphine—DRD2—central nervous system—brain cancer	0.00104	0.0016	CbGeAlD
Apomorphine—HTR2B—brain—brain cancer	0.00102	0.00157	CbGeAlD
Apomorphine—ADRA2A—midbrain—brain cancer	0.00102	0.00157	CbGeAlD
Apomorphine—DRD2—cerebellum—brain cancer	0.00101	0.00156	CbGeAlD
Apomorphine—Asthenia—Temozolomide—brain cancer	0.00101	0.0048	CcSEcCtD
Apomorphine—ADRA2C—central nervous system—brain cancer	0.00101	0.00155	CbGeAlD
Apomorphine—Dyspnoea—Etoposide—brain cancer	0.00101	0.00477	CcSEcCtD
Apomorphine—HTR2A—gonad—brain cancer	0.001	0.00155	CbGeAlD
Apomorphine—Somnolence—Etoposide—brain cancer	0.001	0.00476	CcSEcCtD
Apomorphine—Diarrhoea—Carmustine—brain cancer	0.001	0.00473	CcSEcCtD
Apomorphine—Pruritus—Temozolomide—brain cancer	0.000999	0.00473	CcSEcCtD
Apomorphine—ADRA2A—spinal cord—brain cancer	0.000992	0.00153	CbGeAlD
Apomorphine—ADRA2C—cerebellum—brain cancer	0.000986	0.00152	CbGeAlD
Apomorphine—HTR2A—pituitary gland—brain cancer	0.00098	0.00151	CbGeAlD
Apomorphine—Fatigue—Etoposide—brain cancer	0.000974	0.00461	CcSEcCtD
Apomorphine—Dizziness—Carmustine—brain cancer	0.000966	0.00457	CcSEcCtD
Apomorphine—Constipation—Etoposide—brain cancer	0.000966	0.00457	CcSEcCtD
Apomorphine—Diarrhoea—Temozolomide—brain cancer	0.000966	0.00457	CcSEcCtD
Apomorphine—HTR2A—medulla oblongata—brain cancer	0.000946	0.00146	CbGeAlD
Apomorphine—Dizziness—Temozolomide—brain cancer	0.000934	0.00442	CcSEcCtD
Apomorphine—Feeling abnormal—Etoposide—brain cancer	0.000931	0.00441	CcSEcCtD
Apomorphine—Vomiting—Carmustine—brain cancer	0.000929	0.0044	CcSEcCtD
Apomorphine—Headache—Carmustine—brain cancer	0.000915	0.00433	CcSEcCtD
Apomorphine—HTR1A—brain—brain cancer	0.000911	0.00141	CbGeAlD
Apomorphine—Vomiting—Temozolomide—brain cancer	0.000898	0.00425	CcSEcCtD
Apomorphine—ADRA2A—endocrine gland—brain cancer	0.000893	0.00138	CbGeAlD
Apomorphine—Headache—Temozolomide—brain cancer	0.000884	0.00419	CcSEcCtD
Apomorphine—ADRA2A—head—brain cancer	0.000882	0.00136	CbGeAlD
Apomorphine—Nausea—Carmustine—brain cancer	0.000868	0.00411	CcSEcCtD
Apomorphine—HTR2A—midbrain—brain cancer	0.000864	0.00133	CbGeAlD
Apomorphine—HTR2A—spinal cord—brain cancer	0.000843	0.0013	CbGeAlD
Apomorphine—Nausea—Temozolomide—brain cancer	0.000839	0.00397	CcSEcCtD
Apomorphine—DRD2—brain—brain cancer	0.000824	0.00127	CbGeAlD
Apomorphine—Asthenia—Etoposide—brain cancer	0.000811	0.00384	CcSEcCtD
Apomorphine—ADRA2A—central nervous system—brain cancer	0.000805	0.00124	CbGeAlD
Apomorphine—ADRA2C—brain—brain cancer	0.000801	0.00123	CbGeAlD
Apomorphine—Pruritus—Etoposide—brain cancer	0.000799	0.00378	CcSEcCtD
Apomorphine—ADRA2A—cerebellum—brain cancer	0.000786	0.00121	CbGeAlD
Apomorphine—Diarrhoea—Etoposide—brain cancer	0.000773	0.00366	CcSEcCtD
Apomorphine—HTR2A—endocrine gland—brain cancer	0.000759	0.00117	CbGeAlD
Apomorphine—HTR2A—head—brain cancer	0.00075	0.00116	CbGeAlD
Apomorphine—Dizziness—Etoposide—brain cancer	0.000747	0.00354	CcSEcCtD
Apomorphine—Vomiting—Etoposide—brain cancer	0.000718	0.0034	CcSEcCtD
Apomorphine—Headache—Etoposide—brain cancer	0.000708	0.00335	CcSEcCtD
Apomorphine—HTR2A—central nervous system—brain cancer	0.000684	0.00105	CbGeAlD
Apomorphine—Nausea—Etoposide—brain cancer	0.000671	0.00318	CcSEcCtD
Apomorphine—HTR2A—cerebellum—brain cancer	0.000669	0.00103	CbGeAlD
Apomorphine—ADRA2A—brain—brain cancer	0.000639	0.000985	CbGeAlD
Apomorphine—HTR2A—brain—brain cancer	0.000543	0.000837	CbGeAlD
Apomorphine—HTR1A—GPCR downstream signaling—IL2—brain cancer	3.49e-05	0.000249	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—HES1—brain cancer	3.49e-05	0.000249	CbGpPWpGaD
Apomorphine—HTR2C—GPCR downstream signaling—IL2—brain cancer	3.48e-05	0.000248	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—IRS2—brain cancer	3.46e-05	0.000247	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—IRS2—brain cancer	3.46e-05	0.000247	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—NOTCH2—brain cancer	3.46e-05	0.000247	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—SPP1—brain cancer	3.45e-05	0.000246	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—APC—brain cancer	3.44e-05	0.000245	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—PIK3CG—brain cancer	3.44e-05	0.000245	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—HES1—brain cancer	3.43e-05	0.000245	CbGpPWpGaD
Apomorphine—ADRA2C—Hemostasis—TP53—brain cancer	3.43e-05	0.000245	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—PDGFRA—brain cancer	3.43e-05	0.000245	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—PDGFRA—brain cancer	3.42e-05	0.000244	CbGpPWpGaD
Apomorphine—ADRA2C—GPCR downstream signaling—IL2—brain cancer	3.38e-05	0.000241	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—SPP1—brain cancer	3.33e-05	0.000238	CbGpPWpGaD
Apomorphine—ADRA1B—GPCR downstream signaling—IL2—brain cancer	3.33e-05	0.000237	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—PDGFRA—brain cancer	3.32e-05	0.000237	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—SPP1—brain cancer	3.32e-05	0.000237	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—VAV1—brain cancer	3.3e-05	0.000235	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—IL2—brain cancer	3.29e-05	0.000234	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—APC—brain cancer	3.28e-05	0.000234	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—PIK3CG—brain cancer	3.28e-05	0.000234	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—IL2—brain cancer	3.28e-05	0.000234	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—PDGFRA—brain cancer	3.27e-05	0.000233	CbGpPWpGaD
Apomorphine—HTR1D—Signaling by GPCR—EGFR—brain cancer	3.25e-05	0.000232	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—SPP1—brain cancer	3.23e-05	0.00023	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—CCND1—brain cancer	3.2e-05	0.000228	CbGpPWpGaD
Apomorphine—HTR1B—Signaling by GPCR—EGFR—brain cancer	3.18e-05	0.000227	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—SPP1—brain cancer	3.17e-05	0.000227	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—IL2—brain cancer	3.17e-05	0.000226	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—HES1—brain cancer	3.17e-05	0.000226	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—CTNNB1—brain cancer	3.17e-05	0.000226	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—IL2—brain cancer	3.16e-05	0.000225	CbGpPWpGaD
Apomorphine—DRD4—Signaling by GPCR—EGFR—brain cancer	3.13e-05	0.000224	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—IRS2—brain cancer	3.12e-05	0.000223	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—HES1—brain cancer	3.12e-05	0.000222	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—PIK3CG—brain cancer	3.1e-05	0.000221	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—APC—brain cancer	3.1e-05	0.000221	CbGpPWpGaD
Apomorphine—ADRA2C—Metabolism—PIK3CG—brain cancer	3.08e-05	0.00022	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—IL2—brain cancer	3.07e-05	0.000219	CbGpPWpGaD
Apomorphine—DRD2—GPCR downstream signaling—IL2—brain cancer	3.07e-05	0.000219	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—PIK3CG—brain cancer	3.06e-05	0.000218	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—APC—brain cancer	3.06e-05	0.000218	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—APC—brain cancer	3.06e-05	0.000218	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—PIK3CG—brain cancer	3.06e-05	0.000218	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—IL2—brain cancer	3.02e-05	0.000216	CbGpPWpGaD
Apomorphine—HTR2A—GPCR downstream signaling—IL2—brain cancer	3.02e-05	0.000215	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—PDGFRA—brain cancer	3.02e-05	0.000215	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—IRS2—brain cancer	3.02e-05	0.000215	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—IRS2—brain cancer	3e-05	0.000214	CbGpPWpGaD
Apomorphine—HTR2B—Signaling by GPCR—EGFR—brain cancer	2.99e-05	0.000213	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—PDGFRA—brain cancer	2.97e-05	0.000212	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—SPP1—brain cancer	2.93e-05	0.000209	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—IRS2—brain cancer	2.92e-05	0.000208	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—SPP1—brain cancer	2.88e-05	0.000206	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—IRS2—brain cancer	2.87e-05	0.000205	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—HES1—brain cancer	2.83e-05	0.000202	CbGpPWpGaD
Apomorphine—DRD1—Signaling by GPCR—EGFR—brain cancer	2.82e-05	0.000201	CbGpPWpGaD
Apomorphine—ADRA2A—Hemostasis—TP53—brain cancer	2.79e-05	0.000199	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—RELA—brain cancer	2.79e-05	0.000199	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—VEGFA—brain cancer	2.79e-05	0.000199	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—IL2—brain cancer	2.79e-05	0.000199	CbGpPWpGaD
Apomorphine—DRD3—Signaling by GPCR—EGFR—brain cancer	2.78e-05	0.000199	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling by GPCR—EGFR—brain cancer	2.78e-05	0.000199	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—ERBB2—brain cancer	2.77e-05	0.000198	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—STAT3—brain cancer	2.76e-05	0.000197	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—APC—brain cancer	2.76e-05	0.000197	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—PIK3CG—brain cancer	2.76e-05	0.000197	CbGpPWpGaD
Apomorphine—ADRA2A—GPCR downstream signaling—IL2—brain cancer	2.75e-05	0.000196	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—IL2—brain cancer	2.74e-05	0.000196	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—RELA—brain cancer	2.73e-05	0.000195	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—ERBB2—brain cancer	2.71e-05	0.000194	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	2.7e-05	0.000193	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—RELA—brain cancer	2.69e-05	0.000192	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—ERBB2—brain cancer	2.67e-05	0.000191	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—PIK3CG—brain cancer	2.66e-05	0.00019	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—APC—brain cancer	2.66e-05	0.00019	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—APC—brain cancer	2.65e-05	0.000189	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—PIK3CG—brain cancer	2.65e-05	0.000189	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IRS2—brain cancer	2.65e-05	0.000189	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—SPP1—brain cancer	2.62e-05	0.000187	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IRS2—brain cancer	2.6e-05	0.000186	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—APC—brain cancer	2.58e-05	0.000184	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—PIK3CG—brain cancer	2.58e-05	0.000184	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—RELA—brain cancer	2.57e-05	0.000183	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—MYC—brain cancer	2.56e-05	0.000183	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—ERBB2—brain cancer	2.55e-05	0.000182	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—APC—brain cancer	2.54e-05	0.000181	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	2.54e-05	0.000181	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling by GPCR—EGFR—brain cancer	2.51e-05	0.000179	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—IL2—brain cancer	2.51e-05	0.000179	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—EGFR—brain cancer	2.51e-05	0.000179	CbGpPWpGaD
Apomorphine—ADRA2A—Metabolism—PIK3CG—brain cancer	2.5e-05	0.000179	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—IL2—brain cancer	2.49e-05	0.000178	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—IL2—brain cancer	2.46e-05	0.000176	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—CCND1—brain cancer	2.45e-05	0.000175	CbGpPWpGaD
Apomorphine—HTR1A—Signaling by GPCR—EGFR—brain cancer	2.43e-05	0.000173	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—CTNNB1—brain cancer	2.43e-05	0.000173	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—IL2—brain cancer	2.42e-05	0.000173	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—RELA—brain cancer	2.42e-05	0.000173	CbGpPWpGaD
Apomorphine—HTR2C—Signaling by GPCR—EGFR—brain cancer	2.41e-05	0.000172	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—ERBB2—brain cancer	2.4e-05	0.000172	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—CCND1—brain cancer	2.4e-05	0.000171	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—RELA—brain cancer	2.39e-05	0.00017	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—RELA—brain cancer	2.39e-05	0.00017	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—CTNNB1—brain cancer	2.37e-05	0.000169	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—ERBB2—brain cancer	2.37e-05	0.000169	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—ERBB2—brain cancer	2.37e-05	0.000169	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IRS2—brain cancer	2.37e-05	0.000169	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—CCND1—brain cancer	2.36e-05	0.000168	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling by GPCR—EGFR—brain cancer	2.35e-05	0.000168	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—APC—brain cancer	2.34e-05	0.000167	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—PIK3CG—brain cancer	2.34e-05	0.000167	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—CTNNB1—brain cancer	2.34e-05	0.000167	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—IL2—brain cancer	2.31e-05	0.000165	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling by GPCR—EGFR—brain cancer	2.31e-05	0.000165	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—APC—brain cancer	2.3e-05	0.000164	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—PIK3CG—brain cancer	2.3e-05	0.000164	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—CCND1—brain cancer	2.25e-05	0.000161	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—CTNNB1—brain cancer	2.23e-05	0.000159	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—IL2—brain cancer	2.18e-05	0.000156	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—RELA—brain cancer	2.16e-05	0.000154	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—IL2—brain cancer	2.15e-05	0.000153	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—IL2—brain cancer	2.15e-05	0.000153	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—ERBB2—brain cancer	2.14e-05	0.000153	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—VEGFA—brain cancer	2.13e-05	0.000152	CbGpPWpGaD
Apomorphine—DRD2—Signaling by GPCR—EGFR—brain cancer	2.13e-05	0.000152	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—CCND1—brain cancer	2.12e-05	0.000152	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—STAT3—brain cancer	2.11e-05	0.000151	CbGpPWpGaD
Apomorphine—DRD5—Signaling Pathways—TP53—brain cancer	2.11e-05	0.00015	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—CTNNB1—brain cancer	2.1e-05	0.00015	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—CCND1—brain cancer	2.1e-05	0.00015	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—CCND1—brain cancer	2.1e-05	0.00015	CbGpPWpGaD
Apomorphine—HTR2A—Signaling by GPCR—EGFR—brain cancer	2.1e-05	0.00015	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—APC—brain cancer	2.09e-05	0.000149	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	2.09e-05	0.000149	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—VEGFA—brain cancer	2.09e-05	0.000149	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—RELA—brain cancer	2.08e-05	0.000148	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—CTNNB1—brain cancer	2.08e-05	0.000148	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—CTNNB1—brain cancer	2.08e-05	0.000148	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—RELA—brain cancer	2.07e-05	0.000148	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—STAT3—brain cancer	2.07e-05	0.000148	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—ERBB2—brain cancer	2.07e-05	0.000148	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—VEGFA—brain cancer	2.06e-05	0.000147	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—ERBB2—brain cancer	2.06e-05	0.000147	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—STAT3—brain cancer	2.04e-05	0.000145	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—RELA—brain cancer	2.01e-05	0.000144	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—ERBB2—brain cancer	2e-05	0.000143	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—RELA—brain cancer	1.98e-05	0.000141	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—ERBB2—brain cancer	1.97e-05	0.000141	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—MYC—brain cancer	1.96e-05	0.00014	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—VEGFA—brain cancer	1.96e-05	0.00014	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—STAT3—brain cancer	1.94e-05	0.000139	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—IL2—brain cancer	1.94e-05	0.000139	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—MYC—brain cancer	1.92e-05	0.000137	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—EGFR—brain cancer	1.92e-05	0.000137	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling by GPCR—EGFR—brain cancer	1.91e-05	0.000136	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—MYC—brain cancer	1.89e-05	0.000135	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CCND1—brain cancer	1.89e-05	0.000135	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—EGFR—brain cancer	1.88e-05	0.000134	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—CTNNB1—brain cancer	1.87e-05	0.000134	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—IL2—brain cancer	1.87e-05	0.000134	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—IL2—brain cancer	1.86e-05	0.000133	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—VEGFA—brain cancer	1.85e-05	0.000132	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—EGFR—brain cancer	1.85e-05	0.000132	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—STAT3—brain cancer	1.83e-05	0.000131	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—VEGFA—brain cancer	1.83e-05	0.00013	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—VEGFA—brain cancer	1.83e-05	0.00013	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—RELA—brain cancer	1.83e-05	0.00013	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CCND1—brain cancer	1.83e-05	0.00013	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CCND1—brain cancer	1.82e-05	0.00013	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—ERBB2—brain cancer	1.82e-05	0.00013	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—IL2—brain cancer	1.81e-05	0.000129	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—STAT3—brain cancer	1.81e-05	0.000129	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—STAT3—brain cancer	1.81e-05	0.000129	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—CTNNB1—brain cancer	1.81e-05	0.000129	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—MYC—brain cancer	1.81e-05	0.000129	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—CTNNB1—brain cancer	1.8e-05	0.000128	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—RELA—brain cancer	1.8e-05	0.000128	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—ERBB2—brain cancer	1.79e-05	0.000127	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—IL2—brain cancer	1.78e-05	0.000127	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CCND1—brain cancer	1.77e-05	0.000126	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—EGFR—brain cancer	1.77e-05	0.000126	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—CTNNB1—brain cancer	1.75e-05	0.000125	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CCND1—brain cancer	1.74e-05	0.000124	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	1.72e-05	0.000123	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—MYC—brain cancer	1.7e-05	0.000122	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—MYC—brain cancer	1.68e-05	0.00012	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—MYC—brain cancer	1.68e-05	0.00012	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—EGFR—brain cancer	1.67e-05	0.000119	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—VEGFA—brain cancer	1.65e-05	0.000118	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—IL2—brain cancer	1.65e-05	0.000117	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—EGFR—brain cancer	1.64e-05	0.000117	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—EGFR—brain cancer	1.64e-05	0.000117	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—RELA—brain cancer	1.64e-05	0.000117	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—STAT3—brain cancer	1.63e-05	0.000117	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—ERBB2—brain cancer	1.63e-05	0.000116	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—IL2—brain cancer	1.62e-05	0.000116	CbGpPWpGaD
Apomorphine—HTR1D—Signaling Pathways—TP53—brain cancer	1.61e-05	0.000115	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CCND1—brain cancer	1.6e-05	0.000114	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—VEGFA—brain cancer	1.59e-05	0.000114	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—CTNNB1—brain cancer	1.59e-05	0.000113	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—VEGFA—brain cancer	1.58e-05	0.000113	CbGpPWpGaD
Apomorphine—HTR1B—Signaling Pathways—TP53—brain cancer	1.58e-05	0.000113	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CCND1—brain cancer	1.58e-05	0.000113	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—STAT3—brain cancer	1.58e-05	0.000113	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—STAT3—brain cancer	1.57e-05	0.000112	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—CTNNB1—brain cancer	1.56e-05	0.000112	CbGpPWpGaD
Apomorphine—DRD4—Signaling Pathways—TP53—brain cancer	1.55e-05	0.000111	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—VEGFA—brain cancer	1.54e-05	0.00011	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—STAT3—brain cancer	1.53e-05	0.000109	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—MYC—brain cancer	1.52e-05	0.000108	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—VEGFA—brain cancer	1.52e-05	0.000108	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—STAT3—brain cancer	1.5e-05	0.000107	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—EGFR—brain cancer	1.48e-05	0.000106	CbGpPWpGaD
Apomorphine—HTR2B—Signaling Pathways—TP53—brain cancer	1.48e-05	0.000106	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—IL2—brain cancer	1.47e-05	0.000105	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—MYC—brain cancer	1.47e-05	0.000105	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—MYC—brain cancer	1.46e-05	0.000104	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CCND1—brain cancer	1.44e-05	0.000102	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—EGFR—brain cancer	1.43e-05	0.000102	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—EGFR—brain cancer	1.43e-05	0.000102	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	1.42e-05	0.000101	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—MYC—brain cancer	1.42e-05	0.000101	CbGpPWpGaD
Apomorphine—DRD1—Signaling Pathways—TP53—brain cancer	1.4e-05	9.99e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—VEGFA—brain cancer	1.4e-05	9.98e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—MYC—brain cancer	1.4e-05	9.96e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—EGFR—brain cancer	1.39e-05	9.9e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—STAT3—brain cancer	1.38e-05	9.88e-05	CbGpPWpGaD
Apomorphine—DRD3—Signaling Pathways—TP53—brain cancer	1.38e-05	9.85e-05	CbGpPWpGaD
Apomorphine—ADRA1D—Signaling Pathways—TP53—brain cancer	1.38e-05	9.85e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—VEGFA—brain cancer	1.38e-05	9.82e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—EGFR—brain cancer	1.36e-05	9.74e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—STAT3—brain cancer	1.36e-05	9.72e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—MYC—brain cancer	1.29e-05	9.18e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—MYC—brain cancer	1.27e-05	9.03e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—EGFR—brain cancer	1.26e-05	8.98e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—VEGFA—brain cancer	1.25e-05	8.93e-05	CbGpPWpGaD
Apomorphine—ADRA2B—Signaling Pathways—TP53—brain cancer	1.25e-05	8.9e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—STAT3—brain cancer	1.24e-05	8.84e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—EGFR—brain cancer	1.24e-05	8.84e-05	CbGpPWpGaD
Apomorphine—HTR1A—Signaling Pathways—TP53—brain cancer	1.2e-05	8.59e-05	CbGpPWpGaD
Apomorphine—HTR2C—Signaling Pathways—TP53—brain cancer	1.2e-05	8.54e-05	CbGpPWpGaD
Apomorphine—ADRA2C—Signaling Pathways—TP53—brain cancer	1.16e-05	8.31e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—MYC—brain cancer	1.15e-05	8.22e-05	CbGpPWpGaD
Apomorphine—ADRA1B—Signaling Pathways—TP53—brain cancer	1.15e-05	8.18e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—EGFR—brain cancer	1.13e-05	8.04e-05	CbGpPWpGaD
Apomorphine—DRD2—Signaling Pathways—TP53—brain cancer	1.06e-05	7.54e-05	CbGpPWpGaD
Apomorphine—HTR2A—Signaling Pathways—TP53—brain cancer	1.04e-05	7.42e-05	CbGpPWpGaD
Apomorphine—ADRA2A—Signaling Pathways—TP53—brain cancer	9.46e-06	6.75e-05	CbGpPWpGaD
